Jefferies Financial Group’s AbbVie ABBV Stock Holding History

Jefferies Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,000	Closed	-$711K	–	1565
2024 Q4	$711K	Buy	+4,000	New	+$735K	﹤0.01%	1000
2023 Q3	–	Sell	-65,500	Closed	-$8.82M	–	1573
2023 Q2	$8.82M	Buy	65,500 +4,400	+7%	+$645K	0.08%	234
2023 Q1	$9.74M	Sell	61,100 -59,500	-49%	-$9.1M	0.08%	216
2022 Q4	$19.5M	Buy	+120,600	New	+$18.5M	0.14%	124

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jefferies Financial Group's ABBV Position: Q1 2026 in Review

Jefferies Financial Group increased its AbbVie (ABBV) stake by 101% in Q1 2026, buying an estimated $23.3M and bringing the position to 208,359 shares worth $45.3M. The position accounts for 0.31% of the portfolio, ranked #49.

Jefferies Financial Group first reported a position in ABBV in Q1 2017 and has held it in 19 quarters since. The position peaked at $59.9M in Q3 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Jefferies Financial Group held 208,359 shares of AbbVie worth $45.3M as of Q1 2026.
Jefferies Financial Group bought 104,902 AbbVie shares in Q1 2026, an estimated $23.3M.
AbbVie made up 0.31% of Jefferies Financial Group's portfolio in Q1 2026, its #49 holding.
Jefferies Financial Group first reported a position in AbbVie in Q1 2017 and has held it in 19 quarters since.
Jefferies Financial Group's AbbVie position peaked at $59.9M in Q3 2024.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.